We are live on ! Find out more
THMO

ThermoGenesis Holdings, Inc. Common Stock

Delisted

THMO was delisted on the 14th of June, 2024.

2 hedge funds and large institutions have $3 invested in ThermoGenesis Holdings, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% less funds holding

Funds holding: 172 (-15)

100% less capital invested

Capital invested by funds: $127K → $3 (-$127K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 15

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
-15
Holders Change %
-88.24%
% of All Funds
0.03%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
1
Closed
15
Calls
Puts
Net Calls
Net Calls Change

THMO Hedge Fund Activity: Q2 2024 in Review

2 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in ThermoGenesis Holdings, Inc. Common Stock (THMO) for Q2 2024, worth a combined $3 — down 100% from $127K a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of THMO and 0 opened new positions — a net loss of 15 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Raymond James & Associates, exiting entirely with an estimated $46.4K sold.

  • 2 institutional investors held ThermoGenesis Holdings, Inc. Common Stock (THMO) as of Q2 2024, down from 17 in Q1 2024.
  • Funds reported $3 of ThermoGenesis Holdings, Inc. Common Stock stock for Q2 2024, down 100% quarter-over-quarter.
  • 0 funds opened new ThermoGenesis Holdings, Inc. Common Stock positions in Q2 2024 and 15 closed out, a net change of -15 holders.
  • The largest ThermoGenesis Holdings, Inc. Common Stock seller in Q2 2024 was Raymond James & Associates, an estimated $46.4K sold.

Based on aggregated 13F filings for Q2 2024.